Capital Impact Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,343
| Closed | -$951K | – | 77 |
|
|
2024
Q1 | $951K | Sell |
5,343
-383
| -7% | -$68.1K | 1.24% | 29 |
|
|
2023
Q4 | $710K | Hold |
5,726
| – | – | 0.93% | 56 |
|
|
2023
Q3 | $664K | Hold |
5,726
| – | – | 1.11% | 36 |
|
|
2023
Q2 | $672K | Hold |
5,726
| – | – | 0.74% | 52 |
|
|
2023
Q1 | $458K | Buy |
5,726
+307
| +6% | +$24.6K | 0.56% | 79 |
|
|
2022
Q4 | $429K | Buy |
5,419
+269
| +5% | +$21.3K | 0.42% | 100 |
|
|
2022
Q3 | $395K | Buy |
5,150
+872
| +20% | +$66.9K | 0.39% | 107 |
|
|
2022
Q2 | $281K | Buy |
+4,278
| New | +$281K | 0.26% | 168 |
|